Eleftheria Maranou

TIMP-1 is an activator of MHC-I expression in myeloid dendritic cells with implications for tumor immunogenicity (2024)

Genes and Immunity

Langguth Miriam, Maranou Eleftheria, Koskela Saara A., Elenius Oskar, Kallionpää Roosa E., Birkman Eva-Maria, Pulkkinen Otto I., Sundvall Maria, Salmi Marko, Figueiredo Carlos R.

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Novel prognostication biomarker adipophilin reveals a metabolic shift in uveal melanoma and new therapeutic opportunities (2023)

Journal of Pathology

Matareed Maisoon, Maranou Eleftheria, Koskela Saara A, Mehmood Arfa, Kalirai Helen, Coupland Sarah E, Figueiredo Carlos R

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Epigenetic control of CD1D expression as a mechanism of resistance to immune checkpoint therapy in poorly immunogenic melanomas (2023)

Frontiers in Immunology

Wang Mona M, Koskela Saara A, Mehmood Arfa, Langguth Miriam, Maranou Eleftheria, Figueiredo Carlos R

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Eleftheria

Maranou

Contact

Publications

Sort by:

TIMP-1 is an activator of MHC-I expression in myeloid dendritic cells with implications for tumor immunogenicity (2024)

Novel prognostication biomarker adipophilin reveals a metabolic shift in uveal melanoma and new therapeutic opportunities (2023)

Epigenetic control of CD1D expression as a mechanism of resistance to immune checkpoint therapy in poorly immunogenic melanomas (2023)